Shares of Cingulate, Inc. (CING) jumped in overnight trading on Sunday after the U.S. Patent and Trademark Office (PTO) cleared a key patent application tied to the company’s ADHD drug platform, adding another potential catalyst ahead of a major regulatory decision expected in May.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.